vs

Side-by-side financial comparison of American International Group (AIG) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

American International Group is the larger business by last-quarter revenue ($6.5B vs $487.7M, roughly 13.4× CLOVER HEALTH INVESTMENTS, CORP.). American International Group runs the higher net margin — 11.2% vs -10.1%, a 21.3% gap on every dollar of revenue. On growth, American International Group posted the faster year-over-year revenue change (380.9% vs 44.7%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -27.8%).

American International Group, Inc. offers insurance products for commercial, institutional, and individual customers in North America and internationally. The company's General Insurance segment provides general liability, environmental, commercial automobile liability, workers' compensation, casualty, and crisis management insurance products; commercial, industrial, and energy-related property insurance; and aerospace, political risk, trade credit, portfolio solutions, crop, and marine insur...

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

AIG vs CLOV — Head-to-Head

Bigger by revenue
AIG
AIG
13.4× larger
AIG
$6.5B
$487.7M
CLOV
Growing faster (revenue YoY)
AIG
AIG
+336.2% gap
AIG
380.9%
44.7%
CLOV
Higher net margin
AIG
AIG
21.3% more per $
AIG
11.2%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-27.8%
AIG

Income Statement — Q4 2025 vs Q4 2025

Metric
AIG
AIG
CLOV
CLOV
Revenue
$6.5B
$487.7M
Net Profit
$735.0M
$-49.3M
Gross Margin
Operating Margin
10.1%
-10.1%
Net Margin
11.2%
-10.1%
Revenue YoY
380.9%
44.7%
Net Profit YoY
-18.2%
-123.2%
EPS (diluted)
$1.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIG
AIG
CLOV
CLOV
Q4 25
$6.5B
$487.7M
Q3 25
$6.4B
$496.6M
Q2 25
$7.1B
$477.6M
Q1 25
$6.8B
$462.3M
Q4 24
$1.4B
$337.0M
Q3 24
$6.8B
$331.0M
Q2 24
$6.6B
$356.3M
Q1 24
$12.6B
$346.9M
Net Profit
AIG
AIG
CLOV
CLOV
Q4 25
$735.0M
$-49.3M
Q3 25
$519.0M
$-24.4M
Q2 25
$1.1B
$-10.6M
Q1 25
$698.0M
$-1.3M
Q4 24
$898.0M
$-22.1M
Q3 24
$459.0M
$-9.2M
Q2 24
$-4.0B
$7.4M
Q1 24
$1.2B
$-19.2M
Gross Margin
AIG
AIG
CLOV
CLOV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
AIG
AIG
CLOV
CLOV
Q4 25
10.1%
-10.1%
Q3 25
11.2%
-4.9%
Q2 25
21.8%
-2.2%
Q1 25
14.2%
-0.3%
Q4 24
40.6%
-6.4%
Q3 24
9.6%
-2.7%
Q2 24
9.4%
2.0%
Q1 24
16.3%
-6.5%
Net Margin
AIG
AIG
CLOV
CLOV
Q4 25
11.2%
-10.1%
Q3 25
8.2%
-4.9%
Q2 25
16.1%
-2.2%
Q1 25
10.3%
-0.3%
Q4 24
65.9%
-6.6%
Q3 24
6.8%
-2.8%
Q2 24
-60.6%
2.1%
Q1 24
9.7%
-5.5%
EPS (diluted)
AIG
AIG
CLOV
CLOV
Q4 25
$1.36
Q3 25
$0.93
Q2 25
$1.98
Q1 25
$1.16
Q4 24
$1.34
Q3 24
$0.71
Q2 24
$-5.96
Q1 24
$1.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIG
AIG
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$78.3M
Total DebtLower is stronger
$9.2B
Stockholders' EquityBook value
$41.1B
$308.7M
Total Assets
$161.3B
$541.0M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIG
AIG
CLOV
CLOV
Q4 25
$78.3M
Q3 25
Q2 25
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Q1 24
$208.3M
Total Debt
AIG
AIG
CLOV
CLOV
Q4 25
$9.2B
Q3 25
Q2 25
Q1 25
Q4 24
$8.9B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AIG
AIG
CLOV
CLOV
Q4 25
$41.1B
$308.7M
Q3 25
$41.1B
$340.9M
Q2 25
$41.5B
$344.2M
Q1 25
$41.4B
$336.1M
Q4 24
$42.5B
$341.1M
Q3 24
$45.0B
$342.2M
Q2 24
$44.4B
$324.9M
Q1 24
$43.4B
$292.5M
Total Assets
AIG
AIG
CLOV
CLOV
Q4 25
$161.3B
$541.0M
Q3 25
$163.4B
$559.7M
Q2 25
$166.0B
$575.0M
Q1 25
$161.9B
$583.7M
Q4 24
$161.3B
$580.7M
Q3 24
$169.4B
$653.0M
Q2 24
$167.9B
$674.2M
Q1 24
$544.1B
$671.8M
Debt / Equity
AIG
AIG
CLOV
CLOV
Q4 25
0.22×
Q3 25
Q2 25
Q1 25
Q4 24
0.21×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIG
AIG
CLOV
CLOV
Operating Cash FlowLast quarter
$636.0M
$-68.2M
Free Cash FlowOCF − Capex
$-68.7M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$-69.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIG
AIG
CLOV
CLOV
Q4 25
$636.0M
$-68.2M
Q3 25
$1.3B
$12.1M
Q2 25
$1.4B
$5.4M
Q1 25
$-56.0M
$-16.3M
Q4 24
$125.0M
$-85.8M
Q3 24
$1.7B
$50.0M
Q2 24
$930.0M
$44.8M
Q1 24
$519.0M
$25.9M
Free Cash Flow
AIG
AIG
CLOV
CLOV
Q4 25
$-68.7M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$-86.1M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
AIG
AIG
CLOV
CLOV
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
-25.6%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
AIG
AIG
CLOV
CLOV
Q4 25
0.1%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
AIG
AIG
CLOV
CLOV
Q4 25
0.87×
Q3 25
2.59×
Q2 25
1.22×
Q1 25
-0.08×
Q4 24
0.14×
Q3 24
3.70×
Q2 24
6.04×
Q1 24
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons